At the 15th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, David Evans talks with UCLA researcher, David Hardy, MD, about the latest data on antiretroviral options for people who are heavily treatment experienced and learns that the treatment landscape has changed radically.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 1 (of 1 total)
Murph, Port Townsend, WA, 2008-02-13 14:22:11
This is such exciting news for those of us who are treatment experienced and resistant to most or all of the existing meds. The feeling of being near the "end of the line" is a scary burden that wears over time, and this sends us a lot of hope. Thanks for sharing the news, POZ!
Beth Benne, RN, is HIV negative, but
the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as
the director of the student health center at Pierce College, a
community commuter school in Woodland Hills, California.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I recently met a guy who is negative. I did tell him about my status and he decided to kiss me anyway (we didn't go further than that). But a day later, he called and said that he actually had a mouth ulcer that time when we kissed and he was very worried. Asked if he can get the virus from me that way. For that moment, I felt so insulted and yet I felt so bad. It was my first time having a contact with a "negative" guy."